Navigation Links
Array BioPharma To Hold Conference Call To Discuss Clinical Data Presentations In Melanoma And Colorectal Cancer On September 28, 2015
Date:9/25/2015

BOULDER, Colo., Sept. 25, 2015 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq:   ARRY) will hold a conference call to discuss preliminary results from two melanoma trials and a colorectal cancer trial on Monday, September 28, 2015.  Ron Squarer, Chief Executive Officer, and Victor Sandor, M.D., Chief Medical Officer, will lead the call.

The trials include a Phase 2 combination trial of binimetinib and encorafenib in BRAF-mutant melanoma patients (LOGIC2), a Phase 1b/2 combination trial of binimetinib and a CDK4/6 inhibitor in NRAS-mutant melanoma patients and a Phase 2 combination trial of encorafenib and an EGFR inhibitor with or without the addition of a PI3K inhibitor in patients with BRAF-mutant colorectal cancer.  Data from these trials will be presented at the European Society of Medical Oncology's (ESMO) annual European Cancer Conference (ECC) or were presented at the 2015 ESMO World Congress of Gastrointestinal Cancer. Conference Call InformationDate:Monday, September 28, 2015Time:9:00 a.m. eastern timeToll-Free:(844) 464-3927Toll:(765) 507-2598Pass Code:43837177Webcast, including Replay and Conference Call Slides:  http://edge.media-server.com/m/p/ky8z35w4/lan/enAbout Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Six registration studies are currently advancing related to three cancer drugs. These programs include binimetinib (MEK162 / wholly-owned), encorafenib (LGX818 / wholly-owned) and selumetinib (AstraZeneca). For more information on Array, please go to www.arraybiopharma.com.

CONTACT:

Tricia HaugetoArray BioPharma Inc.(303) 386-1193thaugeto@arraybiopharma.com  Logo - http://photos.prnewswire.com/prnh/20121029/LA02195LOGO

 


'/>"/>
SOURCE Array BioPharma
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Array BioPharma Announces Clinical Data Presentations At The 2015 European Cancer Congress
2. Array BioPharma To Present At The Morgan Stanley Global Healthcare Conference
3. Array BioPharma To Present At The Wells Fargo Securities Healthcare Conference
4. Proxsys Rx Adds Turnkey 340B Plan Management to its Array of Services
5. Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015
6. Array BioPharma To Report Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 On August 3, 2015
7. SCIENION and Anteo Partner to Develop Consumables for Better Functionality and Longer Shelf Life of Protein Microarrays
8. Array BioPharma To Present At The Cantor Fitzgerald 2015 Healthcare Conference
9. Global Array Instruments Market 2015-2019 - Advances in Personalized Medicines with Affymetrix, Agilent Technologies & Illumina Dominating
10. Accuratus Lab Services Expands Capabilities with Acquisition of CMC Operation of Array BioPharma
11. Array BioPharma Announces Clinical Data Presentations At The 2015 ASCO Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/14/2017)... , June 14, 2017 The Bio ... City of Fremont and the ... the bio-pharma industry in California ... enabling executive networking, and fostering workforce development. The primary ... and growth of start-ups, as well as small and ...
(Date:6/12/2017)... 12, 2017 Kineta, Inc., a biotechnology company focused ... Vice President of R&D and Head of Virology Kristin ... Preparedness for the Northwest and Beyond meeting sponsored by ... 14, 2017 from 8:30-10:30 AM PDT at the Agora Conference ... Dr. Bedard will be joined by other leaders in ...
(Date:6/9/2017)... PALO ALTO, Calif. , June 9, 2017 /PRNewswire/ ... medical device company focused on the design, manufacture, sale ... updated the market on the progress of its commercial ... AeroForm is now available in more than one hundred ... country. AeroForm offers a needle-free alternative ...
Breaking Medicine Technology:
(Date:6/25/2017)... ... 25, 2017 , ... Republicans in the United States Senate on Thursday released ... Care Reconciliation Act. It differs significantly from the American Health Care Act, which the ... committee, or the House will have to take up the Senate version as-is, if ...
(Date:6/24/2017)... , ... June 24, 2017 , ... ... offering genetic testing for medications in select Florida and Texas doctors' offices and ... , This new application of genetic testing recognizes the role genes play in ...
(Date:6/23/2017)... ... June 23, 2017 , ... The Rhode Island Quality Institute ... Alerts and Dashboards, an innovative new service enabling healthcare providers to proactively coordinate ... Alerts and Dashboards provide near real-time data about patients admitted to and/or discharged ...
(Date:6/23/2017)... (PRWEB) , ... June 23, 2017 , ... The Military ... president's nominee for deputy secretary of Veterans Affairs, retired Marine Col. Thomas G. Bowman. ... Affairs. , Bowman brings an intimacy with the issues and challenges veterans ...
(Date:6/23/2017)... ... , ... The Aesthetic Channel has recently highlighted Dr. Ben Talei’s unique approach ... proprietary technique that he calls the AuraLyft Facelift. The AuraLyft does more ... can expect to look refreshed, rejuvenated, and revitalized. , Dr. Talei’s unique approach ...
Breaking Medicine News(10 mins):